Financials data is unavailable for this security.
Cash flow in CNYView more
In 2023, Qyuns Therapeutics Co Ltd did not generate a significant amount of cash. However, Cash Flow from Investing totalled 243.11m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 300.68m for operations while cash generated from financing totalled 61.21m.
Cash flow per share | -2.01 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.80 |
---|---|
Tangible book value per share | 1.78 |
More ▼
Balance sheet in CNYView more
Current ratio | 1.86 |
---|---|
Quick ratio | 1.83 |
Total debt/total equity | 1.36 |
---|---|
Total debt/total capital | 0.5795 |
More ▼